Table 3.
AMR enes | EPEC | ETEC | EAEC | EIEC | EHEC | |||||
---|---|---|---|---|---|---|---|---|---|---|
C | A | C | A | C | A | C | A | C | A | |
qnrB | 6.9 (2.38–20.30) | 0.0 (inf- inf) | 6.8 (1.26–36.84) | inf. (inf- inf) | 25.7 (4.66–142.14) | 0.0 (inf- inf) | 1.4 (0.16–14.10) | – | 0.0 (inf- inf) | 0.0 (inf- inf) |
qnrS | 8.3 (2.99–23.52) | 8.7 (1.10–68.70) | 5.5 (1.03–29.43) | 31.3 (3.23–303.96) | 5.7 (1.31–25.29) | 0.0 (inf- inf) | 3.4 (0.54–22.21) | – | 0.9 (0.11–8.76) | 0.0 (inf- inf) |
aac(6′)-Ib | 15.1 (5.24–43.89) | 2.6 (0.25–27.29) | 2.2 (0.39–13.31) | 7.7 (0.65–92.05) | 5.0 (1.16–21.99) | inf. (inf- inf) | 7.3 (1.15–46.87) | – | 2.2 (0.39–13.31) | 0.0 (inf- inf) |
sulI | 36.0 ((9.71–133.99) | 8.7 (1.10–68.70) | 11.7 (1.32–103.96) | 0.0 (inf- inf) | 7.1 (1.37–37.20) | inf. (inf- inf) | 3.2 (0.53–20.49) | – | 4.5 (0.79–25.70) | 0.0 (inf- inf) |
sulII | 10.3 (3.87–27.62) | 10.6 (2.22–50.77) | 3.5 (0.67–18.38) | 3.1 (0.31–32.42) | 6.3 (1.41–28.33) | inf. (inf- inf) | 5.3 (0.84–33.47) | – | 7.3 (1.27–42.52) | inf. (inf- inf) |
sulIII | 22.8 (2.54–205.95) | 5.7 (0.85–38.54) | 4.4 (0.44–45.88) | 20.6 (2.46–173.35) | 3.1 (0.32–30.69) | 23.7 (1.25–452.35) | 0.0 (inf- inf) | – | 0.0 (inf- inf) | 0.0 (inf- inf) |
dhfrI | 6.0 (2.28–16.17) | 3.9 (0.33–47.27) | 4.5 (0.86–24.25) | 0.0 (inf- inf) | 16.1 (3.02–86.53) | -inf. (inf- inf) | 6.9 (1.09–44.08) | – | 4.5 (0.86–24.25) | 0.0 (inf- inf) |
aac(3)-IV | 4.2 (0.98–18.23) | – | 9.2 (1.40–60.97) | – | 2.2 (0.24–20.51) | – | 3.9 (0.39–40.37) | – | 0.0 (inf- inf) | – |
aadB | 1.2 (0.12–12.57) | 0.0 (inf- inf) | 7.6 (0.67–86.67) | inf. (inf- inf) | 5.3 (0.49–58.12) | 0.0 (inf- inf) | 0.0 (inf- inf) | – | 7.6 (0.67–86.67) | – |
tetA | 21.1 (4.14–107.68) | 8.7 (1.10–68.70) | 0.0 (inf- inf) | 31.3 (3.23–303.96) | 4.4 (0.77–25.76) | 0.0 (inf- inf) | 9.1 (1.33–63.02) | – | 2.4 (0.25–22.82) | 0.0 (inf- inf) |
tetD | 1.9 (0.33–11.21) | – | 0.0 (inf- inf) | – | 3.1 (0.32–30.69) | – | 19.0 (2.45–147.34) | – | 4.4 (0.44–45.88) | – |
tetB | 10.3 (2.81–37.99) | 17.6 (1.46–211.86) | 5.3 (0.87–32.92) | 0.0 (inf- inf) | 3.5 (0.62–19.68) | 48.5 (2.17–1082.45) | 0.0 (inf- inf) | – | 1.9 (0.21–18.01) | 0.0 (inf- inf) |
catI | 1.2 (0.38–4.38) | 0.0 (inf- inf) | 8.0 (1.46–43.84) | -inf. (inf- inf) | 15.7 (3.31–75.02) | 0.0 (inf- inf) | 12.1 (1.85–79.38 | – | 8.0 (1.46–43.84) | 0.0 (inf- inf) |
blaCTX | 9.4 (2.17–40.78) | 4.6 (0.98–21.67) | 0.0 (inf- inf) | 72.8 (6.81–778.05) | 5.1 (0.87–30.30) | -inf. (inf- inf) | 3.4 (0.34–34.49) | – | 2.7 (0.28–26.22) | 0.0 (inf- inf) |
blaSHV | 3.3 (1.04–10.69) | 3.3 (0.57–19.65) | 5.3 (2.00–14.14) | 12.1 (1.64–89.92) | 2.8 (0.52–15.79) | -inf. (inf- inf) | 2.0 (0.21–19.46) | – | 9.6 (1.73–53.63) | -inf. (inf- inf) |
blaTEM | 3.8 (1.17–12.72) | 14.5 (2.13–98.54) | 10.7 (1.90–60.15) | 20.6 (2.46–173.35) | 11.7 (2.51–55.16) | 0.0 (inf- inf) | 2.2 (0.23–21.40) | – | 1.7 (0.19–16.25) | 0.0 (inf- inf) |
Int1 | 8.1 (3.12–21.05) | 5.7 (0.85–38.54) | 3.0 (0.58–15.87) | 20.6 (2.46–173.35) | inf. (inf- inf) | 23.7 (1.25–452.35) | inf. (inf- inf) | – | 3.0 (0.58–15.87) | 0.0 (inf- inf) |
OR odds ratio, inf infinity, C children, A adults